Pacemaker Market Analysis, Size, Growth, Share,Outlook & Forecast to 2027 | Grand View Research Inc.
The global pacemaker market size is anticipated to reach USD 5.8 billion by 2027, expanding at a CAGR of 2.9%, as per the new report by Grand View Research, Inc. The increasing prevalence of cardiovascular diseases is a key growth driver for the market. As per the CDC, in 2017, CVDs accounted for about 800,000 deaths in the U.S alone. Moreover, coronary heart disease accounts for the highest number of deaths, followed by stroke and heart failure. As per the British Heart Foundation Centre in 2018, nearly 7.4 million individuals are living with circulatory and heart diseases in the UK. More than 43,000 individual under 75 years of age dies due to cardiac diseases every year in the UK. To curb the rising prevalence of CVDs is government bodies and key market players are channelizing revenues to offer a potential treatment. This is anticipated by the influx of advanced products in this market space. As per the CDC, 2020, more than 15.0% of U.S. adults are physically inactive that shows the prevalence of adult physical inactivity. Technological developments are quickly renovating the market. Key players are focusing on expanding their current portfolio such as in January 2020, BIOTRONIK launched an injectable cardiac monitor, BIOMONITOR III in Japan. It is intended to measure irregular heart rhythms with increased clarity. The injectable cardiac monitor also documents the unexplained syncope. Moreover, in January 2019, Medtronic
launched MyCareLink Heart (TM)-a mobile app for communicating directly with patients via smartphones. Browse Details of Report @ https://www.grandviewresearch.com/industryanalysis/pacemaker-market Pacemaker Market Report Highlights
MRI compatible pacemakers is the fastest-growing segment from 2020 to 2027 owing toa higher patient preference rate as 75% of the patients with pacemakers are likely to get MRI during their lifetimes
Atrial Fibrillation held the largest market share in 2019 owing to the heightened prevalence of growing with age. As per the National Center for Biotechnology Information, 2020, nearly 6 to 12 million people globally are expected to suffer from atrial fibrillation in the US alone by 2050
The biventricular chamber product segment is expected to be the fastest-growing segment from 2020 to 2027. The device is also is known as Cardiac Resynchronization Therapy (CRT) device. An increase in the prevalence of heart failure is one of the major factors driving the growth of the segment
Key companies are adopting new strategies to attain a competitive edge. Product development, collaborations, partnerships, mergers and acquisitions, and regional expansion are few of them.
Pacemaker Market Segmentation Grand View Research has segmented the global pacemaker market on the basis of the product, type, application, end-use, and region. Pacemaker Product Outlook (Revenue, USD Million, 2016 - 2027) Implantable
o
Single Chamber
o
Dual Chamber
o
Biventricular Chamber
External
Pacemaker Type Outlook (Revenue, USD Million, 2016 - 2027) MRI Compatible
Conventional
Pacemaker Application Outlook (Revenue, USD Million, 2016 - 2027)
Arrhythmias o
Atrial Fibrillation
o
Heart Block
o
Long QT Syndrome
Congestive Heart Failure
Others
Pacemaker End-use Outlook (Revenue, USD Million, 2016 - 2027) Hospitals & Cardiac Centers
Ambulatory Surgical Centers
Others
Get Sample of Report @ https://www.grandviewresearch.com/industry-analysis/pacemakermarket/request/rs1
Pacemaker Regional Outlook (Revenue, USD Million, 2016 - 2027) North America
o
The U.S.
o
Canada
Europe o
The U.K.
o
Germany
o
France
o
Italy
o
Spain
Asia Pacific o
Japan
o
China
o
India
o
Australia
Latin America o
Brazil
o
Mexico
Middle East & Africa
o
South Africa
o
Saudi Arabia
o
UAE
List of Key Players of Pacemaker Market Boston Scientific Corporation
Zoll Medical Corporation
Medtronic
BIOTRONIK
MicroPort Scientific Corporation
Cook Medical
MEDICO SpA
Pacetronix
Oscor Inc.
Osypka Medical GmbH
Table of Content
Chapter 1 Methodology and Scope 1.1 Market Segmentation and Scope 1.1.1 Estimates And Forecast Timeline 1.2 Research Methodology 1.3 Information procurement 1.3.1 Purchased Database 1.3.2 Gvr’s Internal Database 1.3.3 Secondary Sources 1.3.4 Primary Research 1.3.5 Details Of Primary Research 1.4 Information or Data Analysis 1.4.1 Data Analysis Models 1.5 Market Formulation & Validation 1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1) 1.7 List of Secondary Sources 1.8 List of Primary Sources 1.9 Objectives 1.9.1 Objective 1 1.9.2 Objective 2 1.9.3 Objective 3 1.9.4 Objective 4 Chapter 2 Executive Summary 2.1 Market Outlook Chapter 3 Pacemaker Market Variables, Trends, and Scope 3.1 Market Lineage Outlook 3.1.1 Parent Market Outlook 3.1.2 Ancillary Market Outlook 3.2 Penetration and Growth Prospect Mapping 3.3 Pacemaker Market Dynamics 3.4 Market Dynamics Continue……… About Grand View Research, Inc.: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact: Sherry James Corporate Sales Specialist, USA
Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: sales@grandviewresearch.com For More Information: http://www.grandviewresearch.com